Cargando…
What Do We Really Know About VBID? Quality of the Evidence and Ethical Considerations for Health Plan Sponsors
Advocates of value-based insurance design (VBID) have argued based on break-even economic modeling that VBID can be effective but acknowledge that direct medical savings from increased use of services with strong evidence of clinical benefit are unlikely to finance the entire [VBID] investment in th...
Autores principales: | Fairman, Kathleen A., Curtiss, Frederic R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438081/ https://www.ncbi.nlm.nih.gov/pubmed/21348548 http://dx.doi.org/10.18553/jmcp.2011.17.2.156 |
Ejemplares similares
-
VBID, the PPACA, and FREEE Medications: Did Politics Trump the Evidence About Cost Sharing?
por: Fairman, Kathleen A., et al.
Publicado: (2012) -
What Do We Really Know About Neutron Stars?
por: Woltjer, Lodewijk
Publicado: (2003) -
Robotic Radical Prostatectomy: What Do We Really Know about Its Outcomes?
por: Naselli, Angelo
Publicado: (2016) -
Connexin 43 in Mitochondria: What Do We Really Know About Its Function?
por: Boengler, Kerstin, et al.
Publicado: (2022) -
The Science of Soy: What Do We Really Know?
por: Barrett, Julia R.
Publicado: (2006)